ArriVent Biopharma
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $191M
Investors
- 18
About ArriVent Biopharma
Based in Pennsylvania, US, and founded in 2021, ArriVent Biopharma, Inc. operates as a company that focuses on accelerating the global development of innovative biopharmaceutical products from pharmaceutical companies and other emerging biotech hubs. Stuart Lutzker and Bing Yao co-founded the company. In March 2023, ArriVent Biopharma, Inc. ArriVent Biopharma has a network of biotechs and big Pharma that provides the company with access to drug candidates at various development stages from biotech hubs. The company identifies potential candidates focusing on compounds validated through rigorous discovery and development processes and aims to commercialize these medicines globally for patients with a broad range of diseases, starting with oncology.S. FDA to further develop furmonertinib in patients with epidermal growth factor receptor tyrosine kinase inhibitor EGFR, and potentially other solid tumors, by the end of 2021. The company also plans to expand the team with in-depth scientific and clinical development expertise and will continue to support the buildout of its portfolio of innovative medicines.
Who invested in ArriVent Biopharma
18 investors across 2 rounds
See all investors in ArriVent Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ArriVent Biopharma
Who invested in ArriVent Biopharma?
ArriVent Biopharma has 18 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ArriVent Biopharma raised?
ArriVent Biopharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ArriVent Biopharma last raise money?
ArriVent Biopharma's most recent round on record is a Series B, in Dec 2022.
What does ArriVent Biopharma do?
Based in Pennsylvania, US, and founded in 2021, ArriVent Biopharma, Inc.
Where is ArriVent Biopharma headquartered?
ArriVent Biopharma is headquartered in US.
Which VCs invest in companies like ArriVent Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ArriVent Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ArriVent Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.